Evidence map›Paper›PMID 41051259›Full record

ArticleSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association2025

Large duct primary sclerosing cholangitis with or without inflammatory bowel disease in Saudi patients.

Hamdan S AlGhamdi, Nawaf M AlYahya, Ibrahim M Bahabri, Majed A Al Ashaikh, Abdulrahman K Habib, Abdulaziz A AlAhmary, Nuha Al Ajlan, Abdulrahman I AlAbdulgader, Abduljaleel M Alalwan, Faisal M Sanai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hamdan S AlGhamdiKing Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Nawaf M AlYahyaDepartment of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Ibrahim M BahabriDepartment of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Majed A Al AshaikhDepartment of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Abdulrahman K HabibDepartment of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Abdulaziz A AlAhmaryDepartment of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Nuha Al AjlanDepartment of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Abdulrahman I AlAbdulgaderDepartment of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Abduljaleel M AlalwanKing Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Faisal M SanaiGastroenterology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biliary diseasescirrhosisinflammatory bowel diseaseoverall survival

Identifiers

PMID41051259
PMCPMC12622383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.